Luminex
Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus
"We have been working on multiple solutions to augment our NxTAG and ARIES offerings in order to facilitate and automate the detection of SARS-CoV-2," said Nachum "Homi" Shamir, President and CEO of Luminex.
Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance
Luminex notes the GI Flex Assay is an automated test for the detection and identification of enteric bacteria, viruses, parasites, and toxins in stool samples.